Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18,578,488
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
1,065,645
-
Shares change
-
+1,065,645
-
Total reported value, excl. options
-
$3,015,000
-
Value change
-
+$3,014,993
-
Number of buys
-
9
-
Price
-
$2.83
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q3 2021
As of 30 Sep 2021 UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) had 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,065,645 shares of stock of the company.
Largest 9 holders included Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, SANDERS MORRIS HARRIS LLC, Frontier Wealth Management LLC, TANDEM CAPITAL MANAGEMENT CORP /ADV, BlackRock Inc., and UBS Group AG.
This table shows 9 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.